Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. DPZ
2. NVDA
3. BAC
4. DRS
5. GS
6. ACI
7. UNH
8. ORCL
9. JPM
10. AVAV

Go back to Novo Nordisk completes $4.7 billion acquisition of Akero Therapeutics

Novo Nordisk has completed its acquisition of Akero Therapeutics

December 9, 2025 8:52 AM EST

Bagsværd, Denmark and South San Francisco, CA, US, 9 December 2025 Novo Nordisk and Akero Therapeutics Inc. (Akero) (Nasdaq: AKRO) today announced that Novo Nordisks acquisition of Akero, announced on 9 October 2025, has been completed.

With the completion of the transaction, Novo Nordisk has acquired all outstanding shares of common stock and common stock equivalents of Akero for 54 USD per share in cash (or aggregated value of 4.7 billion USD) and a non-transferable Contingent Value Right (CVR). Each CVR entitles its holder to an additional payment of 6 USD per share in cash (or aggregated value of 0.5... More